Q3 2011

Filed Mar 21, 2011 · 10-Q · 49 days after period end · 0001354488-11-000902

Q3 2011 · 10-Q

Revenue

$26.59K

no prior Q3 2010 on file

Net Income

$2.54M

no prior Q3 2010 on file

EPS Diluted

-$0.11

no prior Q3 2010 on file

Gross Profit$26,589—

Operating Income

Same quarter

no prior Q3 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jan 31, 2011 · filed Mar 21, 2011 · 49 d after period end

Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR